Arcadia Biosciences, Inc.
RKDA· Nasdaq
Released Nov 10, 2022, after the close
10-Q filed Nov 10, 2022, 41 days after period end · 0000950170-22-024557
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Revenue | $1.57M | $2.38M | $314.00K | $392.00K |
| Net Income | -$2.87M | -$2.18M | -$6.39M | -$14.19M |
| EPS Diluted |
Arcadia Biosciences, Inc. · CIK 1469443 · Engraved from SEC EDGAR
| -$4.67 |
| -$0.10 |
| -$0.60 |
| -$2.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.